Bio Impact Capital LLC Portfolio Holdings

Bio Impact Capital LLC

  • $511 Million
  • Q2 2025

Bio Impact Capital LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $511 Million distributed in 44 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $57.6M, Madrigal Pharmaceuticals, Inc. with a value of $30.4M, Zai Lab LTD with a value of $26.1M, Guardant Health, Inc. with a value of $23M, and Edgewise Therapeutics, Inc. with a value of $22.6M.

Examining the 13F form we can see an decrease of $29.5M in the current position value, from $540M to 511M.

Bio Impact Capital LLC is based out at Cambridge, MA

Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $511 Million
Healthcare: $511 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$332M
$57.6 Million 11.28% of portfolio
7,648,268
Q3 2021 Reduced 3.36%
$6.14B
$30.4 Million 5.95% of portfolio
100,415
Q1 2025 New
$3.36B
$26.1 Million 5.1% of portfolio
745,060
Q2 2025 Reduced 10.63%
$5.63B
$23 Million 4.51% of portfolio
442,656
Q1 2025 Reduced 2.23%
$846M
$22.6 Million 4.42% of portfolio
1,720,741
Q2 2025 Added 55.66%
$2.41B
$21.6 Million 4.23% of portfolio
760,022
Q2 2025 Added 6.41%
$3.24B
$21.4 Million 4.19% of portfolio
438,477
Q2 2025 Reduced 0.34%
$428M
$18.6 Million 3.65% of portfolio
3,406,955
Q2 2025 Reduced 0.62%
$377M
$17.6 Million 3.44% of portfolio
1,729,378
Q2 2025 Added 23.57%
$15.5B
$16.7 Million 3.27% of portfolio
98,924
Q2 2025 Reduced 37.01%
$4.49B
$15.7 Million 3.08% of portfolio
549,262
Q2 2025 Added 62.69%
$2.04B
$14.8 Million 2.9% of portfolio
313,571
Q2 2025 Reduced 0.78%
$321M
$14.6 Million 2.86% of portfolio
5,622,505
Q2 2025 Reduced 33.4%
$1.97B
$14.4 Million 2.82% of portfolio
395,700
Q2 2025 Reduced 0.69%
$1.01B
$14.2 Million 2.78% of portfolio
614,282
Q2 2025 Added 8.3%
$1.37B
$13.8 Million 2.71% of portfolio
341,496
Q2 2025 New
$572M
$13.3 Million 2.6% of portfolio
563,075
Q2 2025 Added 35.45%
$1.53B
$12.3 Million 2.42% of portfolio
428,975
Q2 2025 Reduced 32.12%
$3.09B
$11.6 Million 2.27% of portfolio
315,722
Q2 2025 Reduced 0.43%
$610M
$10.5 Million 2.06% of portfolio
2,889,125
Q2 2025 New
$215M
$10.1 Million 1.98% of portfolio
2,378,762
Q2 2025 Reduced 18.83%
$2.24B
$10.1 Million 1.98% of portfolio
323,398
Q2 2025 Added 6.59%
$734M
$9.78 Million 1.92% of portfolio
1,505,262
Q2 2025 Reduced 0.29%
$10.9M
$9.71 Million 1.9% of portfolio
14,705,882
Q4 2024 New
$220M
$9.56 Million 1.87% of portfolio
3,903,081
Q2 2025 Added 141.19%
$259M
$9.14 Million 1.79% of portfolio
983,780
Q2 2025 Reduced 0.33%
$504M
$9.01 Million 1.76% of portfolio
4,622,590
Q2 2025 Reduced 0.64%
$533M
$8.96 Million 1.75% of portfolio
789,698
Q2 2025 Added 13.79%
$403M
$7.9 Million 1.55% of portfolio
2,282,680
Q2 2025 Reduced 0.58%
$141M
$6.82 Million 1.34% of portfolio
2,953,562
Q2 2025 New
$1.6B
$5.5 Million 1.08% of portfolio
321,696
Q2 2025 New
$254M
$2.85 Million 0.56% of portfolio
4,911,948
Q2 2025 Reduced 25.49%
$35.4M
$2.63 Million 0.51% of portfolio
2,408,810
Q1 2025 Added 0.87%
$278M
$1.87 Million 0.37% of portfolio
555,187
Q2 2025 Reduced 1.38%
$65.4M
$1.14 Million 0.22% of portfolio
819,924
Q1 2025 Reduced 33.4%
$13.1M
$1.06 Million 0.21% of portfolio
4,411,821
Q2 2025 Reduced 9.86%
$0
$0 0.0% of portfolio
1,303,399
Q2 2025 Reduced 0.74%
Cartesian Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 13.25%
Solid Biosciences Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 0.47%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$3.19B
$2,000 0.0% of portfolio
37
Q2 2025 New
Dbv Technologies S A
-
$0 0.0% of portfolio
-
Q2 2025 New
Mbx Biosciences Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 14.25%

Summary

  • Portfolio
  • No. of Stocks 44
  • Current Value $511 Million
  • Prior Value $540 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 8 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email